Exicure (XCUR) Total Current Liabilities (2016 - 2026)
Exicure (XCUR) reported Total Current Liabilities of $4.5 million for Q1 2026, up 14.68% on a YoY basis from $3.9 million in Q1 2025, and up 14.71% quarter-over-quarter from $3.9 million in Q4 2025.
Exicure (XCUR) Total Current Liabilities (2016 - 2026) Analysis & Trends
Exicure has reported Total Current Liabilities for 11 years, with the latest figure at $4.5 million in Q1 2026.
- For the quarter ending Q1 2026, Total Current Liabilities rose 14.68% year-over-year to $4.5 million; the trailing twelve-month figure through Mar 2026 stood at $4.5 million (up 14.68% YoY), and the FY2025 full-year result was $3.9 million, up 26.6% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $4.5 million, up from $3.9 million in the prior quarter.
- The five-year high for Total Current Liabilities was $25.7 million in Q3 2022, with the low at $1.4 million in Q2 2023.
- Historically, Total Current Liabilities has averaged $6.4 million across 5 years, with a median of $3.4 million in 2024.
- Annual changes were most pronounced in 2022 — Total Current Liabilities slumped 95.19% — and 2024, when it surged 139.76%.
- Exicure's Total Current Liabilities stood at $1.6 million in 2022, then surged by 53.14% to $2.5 million in 2023, then grew by 22.35% to $3.1 million in 2024, then gained by 26.6% to $3.9 million in 2025, then increased by 14.71% to $4.5 million in 2026.
- The last three Total Current Liabilities figures came in at $4.5 million (Q1 2026), $3.9 million (Q4 2025), and $2.8 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 1.70 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 16.35 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 636.40 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 13.42 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 3.88 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 72.86 Mn |
| 10 | Exicure | 19.38 Mn | 16.77 Mn | - | 4.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.46 Mn |
| Dec 31, 2025 | 3.89 Mn |
| Sep 30, 2025 | 2.77 Mn |
| Jun 30, 2025 | 4.57 Mn |
| Mar 31, 2025 | 3.89 Mn |
| Dec 31, 2024 | 3.07 Mn |
| Sep 30, 2024 | 3.66 Mn |
| Jun 30, 2024 | 3.43 Mn |
| Mar 31, 2024 | 2.66 Mn |
| Dec 31, 2023 | 2.51 Mn |
| Sep 30, 2023 | 2.22 Mn |
| Jun 30, 2023 | 1.43 Mn |
| Mar 31, 2023 | 2.73 Mn |
| Dec 31, 2022 | 1.64 Mn |
| Sep 30, 2022 | 25.71 Mn |
| Jun 30, 2022 | 19.66 Mn |
| Mar 31, 2022 | 21.36 Mn |
| Dec 31, 2021 | 34.07 Mn |
| Sep 30, 2021 | 21.98 Mn |
| Jun 30, 2021 | 12.75 Mn |